Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Weigel

Showing results (241-250 of 423) with videos related to

Pageof 43
Sort By:
Surgery|August 31, 2019
Discordant findings on preoperative imaging for primary hyperparathyroidism and thyroid disease: Choosing the path to followAnna C Beck, Abhishek K Kashyap, Geeta Lal, et al.
Cancer Chemotherapy and Pharmacology|December 30, 2016
First-dose and steady-state pharmacokinetics of orally administered crizotinib in children with solid tumors: a report on ADVL0912 from the Children's Oncology Group Phase 1/Pilot ConsortiumFrank M Balis, Patrick A Thompson, Yael P Mosse, et al.
International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience|May 31, 2014
Role of ornithine decarboxylase and the polyamines in nervous system development: Short-term postnatal administration of α-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylaseT A Slotkin, W L Whitmore, L Lerea, et al.
Journal of the American College of Surgeons|December 3, 2024
American College of Surgeons Cancer Program Annual Report from 2021 Participant User FileElizabeth B Habermann, Courtney N Day, Bryan E Palis, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 1, 1992
Anomalous origin of the left coronary artery. A twenty-year review of surgical managementC L Backer, M J Stout, V R Zales, et al.
JAMA Surgery|May 6, 2026
Association of Rectal Cancer Accreditation with Patient Volume and Procedural Trends in the USAnthony Loria, Yusheng Jia, Ronald J Weigel, et al.
Journal of the American College of Surgeons|September 19, 2024
Social Vulnerability and Receipt of Guideline-Concordant Care among Patients with Colorectal CancerKelley Chan, Bryan E Palis, Joseph H Cotler, et al.
Pediatric Blood & Cancer|April 21, 2021
A phase 1 study of prexasertib (LY2606368), a CHK1/2 inhibitor, in pediatric patients with recurrent or refractory solid tumors, including CNS tumors: A report from the Children's Oncology Group Pediatric Early Phase Clinical Trials Network (ADVL1515)Thomas Cash, Elizabeth Fox, Xiaowei Liu, et al.
Annals of Surgical Oncology|April 20, 2018
Nipple-Sparing Mastectomy is Not Associated with a Delay of Adjuvant TreatmentEmily L Albright, Mary C Schroeder, Kendra Foster, et al.
Cancer|September 9, 2017
Historical time to disease progression and progression-free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early-phase trialsWendy B London, Rochelle Bagatell, Brenda J Weigel, et al.
Pageof 43

Showing results (241-250 of 423) with videos related to

Sort By:
Pageof 43
Surgery|August 31, 2019
Discordant findings on preoperative imaging for primary hyperparathyroidism and thyroid disease: Choosing the path to followAnna C Beck, Abhishek K Kashyap, Geeta Lal, et al.
Cancer Chemotherapy and Pharmacology|December 30, 2016
First-dose and steady-state pharmacokinetics of orally administered crizotinib in children with solid tumors: a report on ADVL0912 from the Children's Oncology Group Phase 1/Pilot ConsortiumFrank M Balis, Patrick A Thompson, Yael P Mosse, et al.
International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience|May 31, 2014
Role of ornithine decarboxylase and the polyamines in nervous system development: Short-term postnatal administration of α-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylaseT A Slotkin, W L Whitmore, L Lerea, et al.
Journal of the American College of Surgeons|December 3, 2024
American College of Surgeons Cancer Program Annual Report from 2021 Participant User FileElizabeth B Habermann, Courtney N Day, Bryan E Palis, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 1, 1992
Anomalous origin of the left coronary artery. A twenty-year review of surgical managementC L Backer, M J Stout, V R Zales, et al.
JAMA Surgery|May 6, 2026
Association of Rectal Cancer Accreditation with Patient Volume and Procedural Trends in the USAnthony Loria, Yusheng Jia, Ronald J Weigel, et al.
Journal of the American College of Surgeons|September 19, 2024
Social Vulnerability and Receipt of Guideline-Concordant Care among Patients with Colorectal CancerKelley Chan, Bryan E Palis, Joseph H Cotler, et al.
Pediatric Blood & Cancer|April 21, 2021
A phase 1 study of prexasertib (LY2606368), a CHK1/2 inhibitor, in pediatric patients with recurrent or refractory solid tumors, including CNS tumors: A report from the Children's Oncology Group Pediatric Early Phase Clinical Trials Network (ADVL1515)Thomas Cash, Elizabeth Fox, Xiaowei Liu, et al.
Annals of Surgical Oncology|April 20, 2018
Nipple-Sparing Mastectomy is Not Associated with a Delay of Adjuvant TreatmentEmily L Albright, Mary C Schroeder, Kendra Foster, et al.
Cancer|September 9, 2017
Historical time to disease progression and progression-free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early-phase trialsWendy B London, Rochelle Bagatell, Brenda J Weigel, et al.
Pageof 43